MediciNova, Inc. (MNOV)
NASDAQ: MNOV · Real-Time Price · USD
1.371
+0.011 (0.81%)
Mar 9, 2026, 4:00 PM EDT - Market closed
MediciNova Employees
MediciNova had 13 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$31,512
Profits / Employee
-$922,920
Market Cap
67.48M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| TScan Therapeutics | 148 |
| XBiotech | 88 |
| InflaRx | 74 |
| Mereo BioPharma Group | 36 |
| eXoZymes | 31 |
| Q32 Bio | 26 |
| Annovis Bio | 15 |
| Cingulate | 13 |
MNOV News
- 5 weeks ago - MediciNova Announces 100 Patients Enrolled in SEANOBI Study Expanded-Access-Program (EAP) Evaluating MN‑166 (ibudilast) in ALS patients - GlobeNewsWire
- 2 months ago - 2026 New Year's Greetings from the CEO - GlobeNewsWire
- 2 months ago - MediciNova Announces Completion of Patient Enrollment Evaluating MN-166 (ibudilast) in the Prevention of Chemotherapy-induced Peripheral Neuropathy - GlobeNewsWire
- 3 months ago - MediciNova Announces Update and Basic Characteristic Randomized Patients' of Phase 2/3 Clinical Trial of MN-166 (Ibudilast) in ALS (COMBAT-ALS Clinical Trial) Presented at the 36th International Symposium on ALS/MND - GlobeNewsWire
- 3 months ago - MediciNova Appoints Dr. Christopher Breder, MD, PhD as Clinical and Regulatory Advisor - GlobeNewsWire
- 4 months ago - MediciNova Wins Contract Research and Development Innovation Award at 2025 BioTech Breakthrough Awards - GlobeNewsWire
- 4 months ago - MediciNova Compounds Demonstrate Novel Therapeutic Approach for Atherosclerosis in Peer-Reviewed Publication - GlobeNewsWire
- 5 months ago - MediciNova to Present at the LD Micro Main Event XIX Investor Conference - GlobeNewsWire